Every imaging study starts with a biological question. Is the tumor responding? How is the brain changing? Will a new tracer find its target? Answering questions like these takes more than an image. It takes the right model, the right modality, reliable reagents, rigorous quantification and people who understand the science.
Bruker's foundation is preclinical imaging instrumentation across optical imaging, PET, SPECT, CT, MRI and hyperpolarized metabolic imaging. Around that core, we now offer human-relevant organ-on-a-chip models from MIMETAS, optical imaging reagents, pmod analysis software, and application expertise, training and service. Together, they help researchers move from data to biological answers with greater confidence.
From research question to answer:
From tracking tumor response with LAGO optical imaging and microCT to following radiopharmaceuticals with Si78 PET/CT and CUBE SPECT, Bruker supports the questions at the center of EMIM 2027. Explore the brain with BioSpec Maxwell MRI, watch metabolism in real time with Dynamis, and add a human-relevant perspective with organ-on-a-chip models, all backed by pmod analysis and expert support.
Join us in Bologna, 9 to 12 March 2027. Bring your research question, and our scientists will help you explore the paths that could lead to your answer.
Location: Bologna, Italy
Date: March 9-12, 2027
Register for EMIM 2027